Last week, WHF CEO Jean-Luc Eiselé and World Hypertension League President Daniel Lackland attended a meeting of the Coalition for Access to NCD Medicines and Products, a PATH initiative dedicated to increasing access to essential medicines and health products for noncommunicable diseases (NCDs) to reduce the impact of diseases such as diabetes, hypertension, and cardiovascular disease. The World Heart Federation Advocacy team was also present at the event.
The global, multisectoral Coalition for Access to NCD Medicines and Products works with ministries of health to address barriers and identify opportunities for the procurement, supply, distribution, and rational use of needed products through technical support, advocacy, and resource mobilization. Along with the World Heart Federation and the World Hypertension League (which is also a member of the Global Coalition for Circulatory Health), members include government agencies, private-sector entities, nongovernmental organizations, philanthropic foundations, and academic institutions.
The goal of the Coalition is to achieve or exceed the World Health Organization’s target of 80% availability of the affordable basic technologies and essential medicines, including generics, required to treat major NCDs in both public and private facilities.
Click here to learn more about this initiative.
